CCM Investment Advisers LLC Increases Stock Holdings in Synopsys, Inc. $SNPS

CCM Investment Advisers LLC grew its stake in Synopsys, Inc. (NASDAQ:SNPSFree Report) by 30.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 25,128 shares of the semiconductor company’s stock after purchasing an additional 5,805 shares during the period. CCM Investment Advisers LLC’s holdings in Synopsys were worth $11,803,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in the business. Manchester Capital Management LLC lifted its holdings in shares of Synopsys by 5.3% in the 2nd quarter. Manchester Capital Management LLC now owns 340 shares of the semiconductor company’s stock valued at $174,000 after buying an additional 17 shares during the period. Barden Capital Management Inc. grew its holdings in Synopsys by 1.2% during the fourth quarter. Barden Capital Management Inc. now owns 1,868 shares of the semiconductor company’s stock worth $877,000 after acquiring an additional 23 shares during the period. Mutual Advisors LLC grew its holdings in Synopsys by 2.1% during the third quarter. Mutual Advisors LLC now owns 1,157 shares of the semiconductor company’s stock worth $528,000 after acquiring an additional 24 shares during the period. Alpine Bank Wealth Management raised its position in Synopsys by 89.3% in the third quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock worth $26,000 after acquiring an additional 25 shares in the last quarter. Finally, Valeo Financial Advisors LLC raised its position in Synopsys by 3.9% in the third quarter. Valeo Financial Advisors LLC now owns 666 shares of the semiconductor company’s stock worth $329,000 after acquiring an additional 25 shares in the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Synopsys Stock Down 1.3%

SNPS opened at $410.13 on Thursday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.26 and a current ratio of 1.36. The company has a market cap of $78.57 billion, a price-to-earnings ratio of 63.68, a PEG ratio of 3.39 and a beta of 1.15. Synopsys, Inc. has a one year low of $365.74 and a one year high of $651.73. The business’s fifty day moving average is $447.48 and its two-hundred day moving average is $453.75.

Synopsys (NASDAQ:SNPSGet Free Report) last announced its quarterly earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 earnings per share for the quarter, beating analysts’ consensus estimates of $3.56 by $0.21. The business had revenue of $2.41 billion during the quarter, compared to analysts’ expectations of $2.39 billion. Synopsys had a return on equity of 6.83% and a net margin of 13.76%.During the same quarter last year, the business posted $3.03 earnings per share. The business’s revenue for the quarter was up 65.6% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. Analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

More Synopsys News

Here are the key news stories impacting Synopsys this week:

Insiders Place Their Bets

In other Synopsys news, insider Janet Lee sold 250 shares of Synopsys stock in a transaction dated Monday, January 12th. The shares were sold at an average price of $530.00, for a total transaction of $132,500.00. Following the completion of the transaction, the insider owned 11,959 shares in the company, valued at approximately $6,338,270. The trade was a 2.05% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 0.56% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the stock. Weiss Ratings restated a “hold (c)” rating on shares of Synopsys in a research report on Thursday, January 22nd. Wells Fargo & Company cut their price target on shares of Synopsys from $500.00 to $450.00 and set an “equal weight” rating for the company in a report on Thursday, February 26th. Piper Sandler reduced their price objective on shares of Synopsys from $520.00 to $430.00 and set a “neutral” rating for the company in a research note on Thursday, February 26th. KeyCorp boosted their price objective on shares of Synopsys from $575.00 to $600.00 and gave the stock an “overweight” rating in a report on Thursday, December 11th. Finally, Wall Street Zen upgraded shares of Synopsys from a “sell” rating to a “hold” rating in a research report on Saturday, December 13th. Eight analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average price target of $531.00.

Read Our Latest Stock Report on Synopsys

Synopsys Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

See Also

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.